 Component GO Term   intracellular    And related genes <body> Component GO Term intracellular  and related genes   Total 3163 
Page number 18 * 	  Previous Page   *  Next Page    1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11   |   12   |   13   |   14   |   15   |   16   |   17   |   18   |   19   |   20   |   21   |   22   |   23   |   24   |   25   |   26   |   27   |   28   |   29   |   30   |   31   |   32   |   33   |   34   |   35   |   36   |   37   |   38   |   39   |   40   |   41   |   42   |   43   |   44   |   45   |   46   |   47   |   48   |   49   |   50   |   51   |   52   |   53   |   54   |   55   |   56   |   57   |   58   |   59   |   60   |   61   |   62   |   63   |   64   |   65   |   66   |   67   |   68   |   69   |   70   |   71   |   72   |   73   |   74   |   75   |   76   |   77   |   78   |   79   |   80   |   81   |   82   |   83   |   84   |   85   |   86   |   87   |   88   |   89   |   90   |   91   |   92   |   93   |   94   |   95   |   96   |   97   |   98   |   99   |   100   |   101   |   102   |   103   |   104   |   105   |   106  
    Gene Name  ORF Name  Function GO Term  Process GO Term   Component GO Term   Interacting Genes  Description  Gene Product  Phenotype     EMP24   YGL200C  molecular_function unknown  ER to Golgi transport*   endoplasmic reticulum*   YML012W	YAR002C-A	YAL007C	YDL147W	YGL058W	YNL192W	YBR023C	YLR330W	YMR307W	YDR420W	YLR113W	YPR159W	YHR181W	YLR057W	YGL027C	  type I transmembrane protein, component of COPII-coated, ER-derived transport vesicles  type I transmembrane protein  Null mutant is viable     EMP47   YFL048C  molecular_function unknown  ER to Golgi transport   Golgi apparatus*     47 kDa type I transmembrane protein localized to the Golgi  47 kDa type I transmembrane protein localized to the Golgi  Null mutant is viable     END3   YNL084C  cytoskeletal adaptor activity  actin filament organization*   actin cortical patch (sensu Saccharomyces)   YPL174C	YIR006C	YOR181W	YER022W	YDL029W	YCR009C	YDR388W	  Required for endocytosis and organization of the cytoskeleton    Null mutant is viable and defective in endocytosis     ENO1   YGR254W  phosphopyruvate hydratase activity  gluconeogenesis*   cytoplasm*   YNR036C	YJR045C	YHR013C	YBL105C	  enolase I  enolase I  Null mutant is viable     ENP1   YBR247C  snoRNA binding  processing of 20S pre-rRNA*   nucleus*   YNL132W	YOL010W	YCL059C	YGR090W	YOR056C	YDL148C	YGR081C	YKL143W	YBL004W	YDL014W	YPL012W	YLR175W	YMR128W	YLR186W	YHR148W	YNL075W	YJR002W	YLR180W	YLL011W	YDL060W	YDR449C	YMR093W	YPR144C	YBL056W	YCR057C	YNL207W	YPL204W	YBR017C	YNL244C	YOR080W	YIL061C	YE  Essential nuclear protein  57 kDa protein with an apparent MW of 70 kDa by SDS-PAGE (putative)  Null mutant is inviable     ENT1   YDL161W  cytoskeletal adaptor activity  actin filament organization*   actin cortical patch (sensu Saccharomyces)   YLR116W	YLR206W	YIR006C	YOR111W	  epsin N-terminal homology-containing protein    Null mutant is viable, synthetically lethal with ent2 (YLR206w). ent1/2 double mutants have endocyto     ENT2   YLR206W  cytoskeletal adaptor activity  actin filament organization*   actin cortical patch (sensu Saccharomyces)   YGR169C	YKR036C	YDL161W	YAL041W	YBL106C	  epsin N-terminal homology-containing protein    Null mutant is viable; synthetically lethal with ent1 (YDL161w). ent2/1 double mutants have endocyto     ENT3   YJR125C  cytoskeletal adaptor activity  actin filament organization*   actin cortical patch (sensu Saccharomyces)*   YOR111W	  epsin N-terminal homology-containing protein    unknown     ENT4   YLL038C  cytoskeletal adaptor activity  actin filament organization*   actin cortical patch (sensu Saccharomyces)   YPL161C	YPL242C	YLR039C	YLR262C	  epsin N-terminal homology-containing protein    unknown     ENT5   YDR153C  clathrin binding  Golgi to endosome transport   cytoplasm*   YLR039C	YLR262C	  Epsin N-Terminal homology-containing protein         EPL1   YFL024C  histone acetyltransferase activity  regulation of transcription from Pol II promoter*   histone acetyltransferase complex   YFL039C	YHR099W	YDR359C	YNL030W	YPR023C	YOR244W	YNL107W	YEL018W	YJL098W	  Enhancer of Polycomb-Like (from  D. melanogaster ).  Subunit of the Nucleosomal Acetyltransfera  NuA4 histone acetyltransferase complex component  Null mutant is inviable.     EPT1   YHR123W  ethanolaminephosphotransferase activity  phosphatidylethanolamine biosynthesis   endoplasmic reticulum   YIR038C	YEL017W	YBR038W	  sn-1,2-diacylglycerol ethanolamine- and cholinephosphotranferase  sn-1,2-diacylglycerol ethanolamine- and cholinephosphotranferase  Null mutant is viable     ERG1   YGR175C  squalene monooxygenase activity  ergosterol biosynthesis   endoplasmic reticulum*   YNL311C	  squalene epoxidase; an essential enzyme in the ergosterol-biosynthesis pathway; catalyzes the epoxid  squalene monooxygenase  Null mutant is inviable when cells are grown under aerobic conditions; erg1 null mutants are viable     ERG10   YPL028W  acetyl-CoA C-acetyltransferase activity  ergosterol biosynthesis   cytosol   YPR165W	YGR223C	YNL244C	YPL026C	YBR055C	  induced under stress conditions  acetoacetyl CoA thiolase  Nul mutant is inviable; other mutants are ergosterol biosynthesis defective or nystatin resistant     ERG11   YHR007C  sterol 14-demethylase activity  ergosterol biosynthesis   endoplasmic reticulum   YHR045W	YPR090W	YBL007C	YLR242C	YHR030C	YEL031W	YER083C	YER155C	YDR310C	YHR012W	YKR001C	YGL020C	YOR070C	YDL074C	YLR015W	YMR272C	YBR121C	YNL231C	YJR073C	YDL155W	YOR275C	YML013W	YER031C	YBR283C	YMR022W	YMR264W	YPL170W	    cytochrome P450 lanosterol 14a-demethylase  Null mutant is inviable, erg11 null inviability is suppressed by deletion of ERG3; erg11 mutants are     ERG12   YMR208W  mevalonate kinase activity  ergosterol biosynthesis   cytosol     mevalonate catabolism  mevalonate kinase  Null mutant is inviable and unable to grow vegetatively or germinate spores; mutants exhibit increas     ERG13   YML126C  hydroxymethylglutaryl-CoA synthase activity  ergosterol biosynthesis   mitochondrion*   YNL119W	YFL039C	YIL094C	YLR180W	YKL125W	YDL188C	YJR091C	YMR059W	  involved in mevalonate synthesis  3-hydroxy-3-methylglutaryl coenzyme A synthase       ERG2   YMR202W  C-8 sterol isomerase activity  ergosterol biosynthesis   endoplasmic reticulum   YGL127C	YJR091C	YCR034W	YNL271C	  sterol biosynthesis  C-8 sterol isomerase  synthetic lethal with vma2.     ERG20   YJL167W  dimethylallyltranstransferase activity*  ergosterol biosynthesis*   cytosol   YDL186W	YNL244C	YJR035W	YBR055C	YPL149W	YDR369C	  May be rate-limiting step in sterol biosynthesis pathway  farnesyl diphosphate synthetase (FPP synthetase)  Null mutant is inviable     ERG24   YNL280C  C-14 sterol reductase activity  ergosterol biosynthesis   endoplasmic reticulum   YDL153C	YHR114W	  sterol C-14 reductase  sterol C-14 reductase  Null mutant appears to be inviable in some genetic backgrounds and conditionally lethal in others; e     ERG26   YGL001C  C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity  ergosterol biosynthesis   endoplasmic reticulum*   YGR060W	YBR202W	  one of three enzymatic activities required for the conversion of 4,4-dimethylzymosterol to zymostero  C-3 sterol dehydrogenase       ERG27   YLR100W  3-keto sterol reductase activity  ergosterol biosynthesis   endoplasmic reticulum*   YGL137W	YDL132W	YBL005W	  3-keto sterol reductase  3-keto sterol reductase       ERG3   YLR056W  C-5 sterol desaturase activity  ergosterol biosynthesis   endoplasmic reticulum   YHR128W	YIL074C	YOL099C	YOR167C	YNL271C	  C-5 sterol desaturase  C-5 sterol desaturase  Null mutant is inviable; suppresses syringomycin resistant mutant; sensitive to photoactivated 3-car     ERG4   YGL012W  delta24(24-1) sterol reductase activity  ergosterol biosynthesis   endoplasmic reticulum     Sterol C-24 reductase  sterol C-24 reductase  Null mutant is viable     ERG5   YMR015C  C-22 sterol desaturase activity  ergosterol biosynthesis   endoplasmic reticulum     cytochrome P450 involved in C-22 denaturation of the ergosterol side-chain  cytochrome P450|involved in C-22 denaturation of the ergosterol side-chain  Null mutant is viable     ERG6   YML008C  sterol 24-C-methyltransferase activity  ergosterol biosynthesis   endoplasmic reticulum*   YCL023C	YDL089W	YHR114W	YOR097C	YPL020C	YPR113W	YMR059W	  ergosterol synthesis    The null mutant is viable, cannot methylate ergosterol precursors at C-24, and lacks ergosterol. The     ERG8   YMR220W  phosphomevalonate kinase activity  ergosterol biosynthesis*   cytosol     Involved in isoprene and ergosterol biosynthesis pathways  48 kDa phosphomevalonate kinase  Null mutant is inviable     ERG9   YHR190W  farnesyl-diphosphate farnesyltransferase activity  ergosterol biosynthesis   endoplasmic reticulum   YIR038C	YMR153W	YLR453C	  squalene synthetase  squalene synthetase  Null mutant is inviable     ERI1   YPL096C-A  GTPase inhibitor activity  small GTPase mediated signal transduction   endoplasmic reticulum              ERO1   YML130C  electron carrier activity  protein folding*   endoplasmic reticulum   YLR342W	YLR208W	YML067C	YAL042W	YDR021W	YJL002C	YCR057C	  essential, FAD-dependent oxidase of protein disulfide isomerase    Null mutant is inviable; in ero1-1(ts) mutants newly synthesized carboxypeptidase Y is retained in t   </body> 